[1] Miguel A, Azevedo LF, Araujo M, et al. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf,2012, 21: 1139-1154.
[2] Li L, Jiang W, Wang J. Clinical analysis of 275 cases of acute drug-induced liver disease. Front Med China,2007, 1: 58-61.
[3] 付晓琳,王小东,路立业,等. 人工肝支持系统对药物性肝损伤的临床疗效及安全性分析. 胃肠病学和肝病学杂志,2014, 23: 670-672.
[4] 贺娜,郑洋洋,齐云飞,等. 糖皮质激素联合非生物型人工肝治疗重症药物性肝损伤疗效及安全性. 肝脏,2017, 22: 509-512.
[5] 汪萌,聂青和. 糖皮质激素治疗重型肝炎肝衰竭患者的疗效及并发症临床荟萃分析. 临床肝胆病杂志,2012, 28: 764-770.
[6] Hu P F, Wang P Q, Chen H, et al. Beneficial effect of corticosteroids for patients with severe drug-induced liver injury. J Dig Dis,2016, 17: 618-627.
[7] 于乐成,茅益民,陈成伟. 药物性肝损伤诊治指南. 临床肝胆病杂志,2015, 31: 1752-1769.
[8] Teschke R. Idiosyncratic DILI: analysis of 46,266 cases assessed for causality by RUCAM and published from 2014 to early 2019. Front Pharmacol,2019, 10: 730.
[9] 中华医学会感染病学分会肝衰竭与人工肝学组. 非生物型人工肝治疗肝衰竭指南(2016年版). 中华临床感染病杂志,2016, 9: 97-103.
[10] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版). 中华肝脏病杂志,2019, 27: 18-26.
[11] Russo MW, Galanko JA, Shrestha R, et al. Liver trans-plantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl,2004, 10: 1018-1023.
[12] Bjornsson E, Jerlstad P, Bergqvist A, et al. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol,2005, 40: 1095-1101.
[13] 姚群梅,李朝宏. 人工肝支持系统在药物性肝损伤中的临床应用. 中国医疗前沿,2013, 8: 31-39.
[14] 刘发彬,王超秀,戴福宏,等. 人工肝支持系统治疗药物性肝损伤患者的疗效观察. 疑难病杂志,2015, 14: 353-355.
[15] Shi X L, Zhang Y, Chu X H, et al. Evaluation of a novel hybrid bioartificial liver based on a multi-layer flat-plate bioreactor. World J Gastroenterol,2012, 18: 3752-3760. |
